Stock Events

Stock Events

Pear Therapeutics

$0.000001

7

-$0.00-99% Wednesday 15:23

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

29MarExpected

Q2 2022

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.22

-0.13

-0.05

0.04

Expected EPS

-0.12

Actual EPS

N/A

Financials

-594.7%Profit Margin

Unprofitable

2020

2021

2022

12.69MRevenue

-75.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PEARQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Medtronic offers digital health solutions and medical devices that compete in the therapeutic area similar to Pear Therapeutics.

Abbott Laboratories

Abbott Laboratories provides a range of healthcare solutions including digital therapeutic platforms that rival Pear Therapeutics' offerings.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical and medical devices segments, develops products that can be seen as alternatives to those offered by Pear Therapeutics.

Pfizer is involved in digital health and biopharmaceuticals which competes with Pear Therapeutics in providing therapeutic solutions.

Novartis focuses on innovative healthcare solutions including digital therapeutics, directly competing with Pear Therapeutics.

Thermo Fisher Scientific

Thermo Fisher Scientific operates in the life sciences field, offering products and services that can compete with the digital therapeutic solutions from Pear Therapeutics.

Dexcom, specializing in glucose monitoring systems, competes in the broader digital health market where Pear Therapeutics is also positioned.

Siemens Healthineers offers a wide range of medical technology and digital solutions that compete with Pear Therapeutics' digital health products.

Roche Holding AG develops digital health solutions and medical devices that can be used as alternatives to Pear Therapeutics' products.

Stryker Corporation, known for medical technologies, competes in the digital and therapeutic solutions space overlapping with Pear Therapeutics' market.

About

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Show more...

CEO

Employees

298

Country

United States

ISIN

US7047231052

Listings

0 Comments

Share your thoughts

FAQ

What is Pear Therapeutics stock price today?▼

The current price of PEARQ is $0.00 USD — it has decreased by -99% in the past 24 hours. Watch Pear Therapeutics stock price performance more closely on the chart.

What is Pear Therapeutics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Pear Therapeutics stocks are traded under the ticker PEARQ.

What is Pear Therapeutics revenue for the last year?▼

Pear Therapeutics revenue for the last year amounts to 12.69M USD.

What is Pear Therapeutics net income for the last year?▼

PEARQ net income for the last year is -75.49M USD.

How many employees does Pear Therapeutics have?▼

As of June 14, 2026, the company has 298 employees.

In which sector is Pear Therapeutics located?▼

Pear Therapeutics operates in the Technology sector.

When did Pear Therapeutics complete a stock split?▼

Pear Therapeutics has not had any recent stock splits.